Tourette Syndrome
161
21
25
98
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Published Results
35 trials with published results (22%)
Research Maturity
98 completed trials (61% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.5%
12 terminated out of 161 trials
89.1%
+2.5% vs benchmark
9%
14 trials in Phase 3/4
36%
35 of 98 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 98 completed trials
Clinical Trials (161)
Epidiolex in Obsessive Compulsive Disorder and Related Disorders
Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder
Multimodal Profiling of Response to Pediatric Comprehensive Behavioral Intervention for Tics
Trajectories of Change in Tourette Syndrome
Transcranial Ultrasound Stimulation for Tourette Syndrome
Median Nerve Stimulation for Tourette Syndrome and Chronic Tic Disorder
CBIT+TMS R33 Phase
Role of Frontal Cortex in the Pathophysiology of Gilles de la Tourette Syndrome (GTS)
Remote Delivery of a Mindfulness-based Intervention for Tics
Longitudinal Impact of Stressors in Adults With Tourette Syndrome
SCI-110 in the Treatment of Tourette Syndrome
A Multicenter Pediatric Deep Brain Stimulation Registry
Theta Burst Stimulation to Improve Inhibitory Motor Physiology in Tourette Syndrome
Sensory Symptoms in Tourette Syndrome
Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome
Observational Database on Deep Brain Stimulation in Tourette Syndrome
Characterising Sleep Disorders in Children With Tourette Syndrome
Epidemiology of Assertiveness and Emotion Management Disorders in People With Tourette's Syndrome
Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals